Canine Mast Cell Tumours

Rating:
Webinar rating:
Published on: 21.01.2015

Presenter:

James Elliott BVM&S CertSAM DipECVIM-CA (Oncology) MRCVS
European & RCVS Specialist in Veterinary Oncology

Add to favorites

About The Webinar

Mast Cell Tumours (MCTs) are one of the most common cancers dealt with by veterinary practitioners in the UK. They are round cell tumours and usually occur on the skin; though subcutaneous, mucosal and visceral forms are also seen occasionally. Most are cured by adequate surgical excision but on some cases, such as in awkward anatomic sites, local radiation therapy is required for adequate local control. Unfortunately some dogs develop more aggressive forms of MCT which have high metastatic potential and result in death due to tumour. These dogs are likely to require systemic therapy such as chemotherapy or tyrosine kinase inhibitors (TKIs) to control their disease. Hopefully this webinar will give an overview of the diagnosis, staging and different arms of management of canine MCTs.

CPD/CE Tracker

When you have watched the webinar, click on the 'Add To Tracker' button below. This will add a record to your CPD Tracker dashboard located in the main menu under 'My Membership'. Complete the reflective learning fields for future reference. When you click 'update' the information is saved. You can edit this information at a later date either on the webinar page or in your CPD Tracker dashboard. We recommend you download your record regularly for safekeeping.